Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 1;11(8):3858-3866.
eCollection 2018.

The transplantation of human urine stem cells combined with chondroitinase ABC promotes brain-derived neurotrophic factor and nerve growth factor following spinal cord injury in rats

Affiliations

The transplantation of human urine stem cells combined with chondroitinase ABC promotes brain-derived neurotrophic factor and nerve growth factor following spinal cord injury in rats

Hemu Chen et al. Int J Clin Exp Pathol. .

Abstract

Cells based on therapies are currently gaining momentum in neural tissue engineering to treat spinal cord injury (SCI). The present study aimed to evaluate the effects of the concomitant use of human urine stem cells (hUSCs) and chondroitinase ABC (ChABC) on functional improvement and to explore the expressions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). The SCI model was induced by a falling heavy object. hUSCs were cultured and transplanted into the impaired spinal cord with ChABC administration. The Basso, Beattie and Bresnahan (BBB) scores were valued, and real time PCR, immunofluorescence and Western blot were used to detect the expression of BDNF and NGF. We found that rats receiving both hUSCs and ChABC treatment demonstrated the best functional recovery. In addition, the mRNA and protein expressions of the BDNF and NGF expressions were found to be effectively higher in the combined treatment group than these in the other groups. In conclusion, hUSCs transplantation combined with ChABC administration promotes motor functional recovery in SCI rats, which may be associated with BDNF and NGF regulation.

Keywords: Human urine stem cells; brain-derived neurotrophic factor; chondroitinase ABC; nerve growth factor; spinal cord injury.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
The recovery of motor dysfunction of rats after hUSCs and ChABC transplantation in 14 days. The nerve functions of the rats from each group were evaluated from the baseline to day 14 using the BBB system (n=12 each). SCI: spinal cord injury, hUSCs: human urine stem cells, ChABC: chondroitinase ABC, BBB: Basso, Beattie and Bresnahan.
Figure 2
Figure 2
Hematoxylin-Eosin staining of the spinal cord at the day 14 after hUSCs and ChABC transplantation. A. Sham group; B. SCI group; C. hUSCs+SCI group; D. ChABC+SCI group; E. hUSCs/ChABC+SCI group. SCI: spinal cord injury, hUSCs: human urine stem cells, ChABC: chondroitinase ABC, Scale bars: 50 μm.
Figure 3
Figure 3
mRNA levels of BDNF and NGF of each group were determined by real-time PCR at day 14 after hUSCs and ChABC transplantation. SCI: spinal cord injury, hUSCs: human urine stem cells, ChABC: chondroitinase ABC, BDNF: brain-derived neurotrophic factor, NGF: nerve growth factor.
Figure 4
Figure 4
The immunofluorescence of BDNF and NGF in injured spinal cord at the day 14 after hUSCs and ChABC transplantation. SCI: spinal cord injury, hUSCs: human urine stem cells, ChABC: chondroitinase ABC, BDNF: brain-derived neurotrophic factor, NGF: nerve growth factor, Scale bars: 50 μm.
Figure 5
Figure 5
Mean densities of BDNF and NGF in each group. SCI: spinal cord injury, hUSCs: human urine stem cells, ChABC: chondroitinase ABC, BDNF: brain-derived neurotrophic factor, NGF: nerve growth factor.
Figure 6
Figure 6
The western blot assay of BDNF and NGF in injured spinal cord at the day 14 after hUSCs and ChABC transplantation. SCI: spinal cord injury, hUSCs: human urine stem cells, ChABC: chondroitinase ABC, BDNF: brain-derived neurotrophic factor, NGF: nerve growth factor.

References

    1. Wang GD, Liu YX, Wang X, Zhang YL, Zhang YD, Xue F. The SDF-1/CXCR4 axis promotes recovery after spinal cord injury by mediating bone marrow-derived from mesenchymal stem cells. Oncotarget. 2017;8:11629–11640. - PMC - PubMed
    1. Gianaris A, Liu NK, Wang XF, Oakes E, Brenia J, Gianaris T, Ruan Y, Deng LX, Goetz M, Vega-Alvarez S, Lu QB, Shi R, Xu XM. Unilateral microinjection of acrolein into thoracic spinal cord produces acute and chronic injury and functional deficits. Neuroscience. 2016;326:84–94. - PMC - PubMed
    1. Rouanet C, Reges D, Rocha E, Gagliardi V, Silva GS. Traumatic spinal cord injury: current concepts and treatment update. Arq Neuropsiquiatr. 2017;75:387–393. - PubMed
    1. Chhabra HS, Sarda K. Clinical translation of stem cell based interventions for spinal cord injury-are we there yet? Adv Drug Deliv Rev. 2017;120:41–49. - PubMed
    1. Cheng L, Lei Q, Yin C, Wang HY, Jin K, Xiang M. Generation of urine cell-derived non-integrative human iPSCs and iNSCs: a step-by-step optimized protocol. Front Mol Neurosci. 2017;10:348. - PMC - PubMed

LinkOut - more resources